Alyeska Investment Group, L.P.

Q1 2020 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Brent Cunningham - Chief Compliance Officer
Location
Chicago, IL
Holdings as of
31 Mar 2020
Value $
$61,289,000
Num holdings
2
Filing time
18 Aug 2020, 13:08:12 UTC
Form type
13F-HR/A-1 - New Holdings
Description
Top holdings included ETFC and CZR. Request for Confidential Treatment (15 May 2020): Confidential Treatment Expired on 14 Aug 2020.
Previous filing
Q4 2019 - 14 Feb 2020
Next filing
Q2 2020 - 14 Aug 2020
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 15 May 2020 pursuant to a request for confidential treatment and for which confidential treatment expired on 14 Aug 2020.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Brent Cunningham Chief Compliance Officer Chicago, Illinois 18 Aug 2020

Other Included Managers (3):

Num Name Location File Number
1 Alyeska Master Fund, L.P. Chicago, IL 028-13417
2 Alyeska Master Fund 2, L.P. Chicago, IL 028-16151
3 Alyeska Master Fund 3, L.P. Chicago, IL 028-19522